Haemonetics Corporation is a company in the U.S. stock market and it is a holding in 83 U.S.-traded ETFs. HAE has around 6.1M shares in the U.S. ETF market. The largest ETF holder of HAE is the iShares Core S&P Mid-Cap ETF (IJH), with approximately 1.45M shares. Investors may also find of interest that the ETF with the largest allocation to HAE stock is Invesco DWA Healthcare Momentum ETF (PTH), with a portfolio weight of 1.75%. On average, U.S. ETFs allocate 0.28% of HAE to their portfolios.
Additionally, HAE is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with HAE as a holding is the Invesco S&P Midcap Momentum ETF (XMMO), with a return of 24.92%.